0001171000-15-000070.txt : 20150908 0001171000-15-000070.hdr.sgml : 20150907 20150908142741 ACCESSION NUMBER: 0001171000-15-000070 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150903 FILED AS OF DATE: 20150908 DATE AS OF CHANGE: 20150908 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nexvet Biopharma plc CENTRAL INDEX KEY: 0001618561 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: NATL INST FOR BIOPROCESSING RESEARCH STREET 2: FOSTERS AVENUE, MOUNT MERRION CITY: BLACKROCK CO. DUBLIN STATE: L2 ZIP: 00000 BUSINESS PHONE: 353 1 215 8100 MAIL ADDRESS: STREET 1: NATL INST FOR BIOPROCESSING RESEARCH STREET 2: FOSTERS AVENUE, MOUNT MERRION CITY: BLACKROCK CO. DUBLIN STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: NEXVET BIOPHARMA Ltd DATE OF NAME CHANGE: 20140903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GILES COLIN CENTRAL INDEX KEY: 0001632546 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36828 FILM NUMBER: 151096282 MAIL ADDRESS: STREET 1: C/O NEXVET BIOPHARMA PLC, NATL INSTITUTE STREET 2: FOSTERS AVENUE, MOUNT MERRION CITY: BLACKROCK STATE: L2 ZIP: 00000 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-09-03 0001618561 Nexvet Biopharma plc NVET 0001632546 GILES COLIN C/O NEXVET BIOPHARMA PLC NIBRT, FOSTERS AVENUE, MOUNT MERRION BLACKROCK, CO. DUBLIN L2 IRELAND 0 1 0 0 VP Clinical&Regulatory Affairs Restricted Share Units .125 2015-09-03 4 A 0 16162 0 A 2016-07-01 2020-07-01 Ordinary Shares 16162 16162 D 4,041 of the Restricted Share Units shall vest and become convertible on each of 7/1/16 and 7/1/17 and 4,040 of the Restricted Share Units shall vest and become convertible on each of 7/1/18 and 7/1/19, in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting. /s/ Colin Giles by Geraldine T. Farrell, Attorney-in-Fact 2015-09-08